There is growing evidence that increased DPP-4 activity can potentially influence excessive fat deposition and metabolic dysfunction, which can result in the development of insulin resistance and obesity [14,24]. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.